Diferencia entre revisiones de «Levothyroxine»
(Created page with "==Administration== *Type: Endocrine *Dosage Forms: *Routes of Administration: PO, IV *Common Trade Names: Synthroid ==Adult Dosing== *Myxedema coma: 300-500 mcg IV x1, th...") |
Sin resumen de edición |
||
| (No se muestran 2 ediciones intermedias de 2 usuarios) | |||
| Línea 1: | Línea 1: | ||
==Administration== | ==Administration== | ||
*Type: Endocrine | *Type: Endocrine, synthetic hormone | ||
*Dosage Forms: | *Dosage Forms: Tablet 13mcg, 25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 137mcg, 150mcg, 175mcg, 200mcg. IV 100mcg, 200mcg, 500mcg | ||
*Routes of Administration: PO, IV | *Routes of Administration: PO, IV | ||
*Common Trade Names: Synthroid | *Common Trade Names: Synthroid | ||
| Línea 43: | Línea 43: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
*Synthetic thyroid hormone ( | *Synthetic thyroid hormone (T4) | ||
==Comments== | ==Comments== | ||
| Línea 53: | Línea 53: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Endocrinology]] | |||
Revisión actual - 22:54 22 sep 2019
Administration
- Type: Endocrine, synthetic hormone
- Dosage Forms: Tablet 13mcg, 25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 137mcg, 150mcg, 175mcg, 200mcg. IV 100mcg, 200mcg, 500mcg
- Routes of Administration: PO, IV
- Common Trade Names: Synthroid
Adult Dosing
- Myxedema coma: 300-500 mcg IV x1, then 50-100mcg IV daily until able to tolerate PO
- Hypothyroidism: doses vary
Pediatric Dosing
- Hypothyroid: Doses vary, 1.7-15 mcg/kg/day PO
Special Populations
- Pregnancy Rating: A
- Lactation risk: Infant risk minimal
- Renal dosing: Not defined
- Hepatic dosing: Not defined
Contraindications
- Allergy to class/drug, hypersensitivity to glycerol
- Uncorrected adrenal insufficiency (may precipitate acute adrenal crisis)
- Acute MI
- Subclinical or overt thyrotoxicosis, nontoxic diffuse goiter, nodular thyroid disease
Adverse Reactions
Serious
- MI, heart failure, tachycardia, cardiac arrest
- Pseudotumor, seizure
- Dyspnea
- Hyperthyroid
- Decreased bone mineral density, hip fracture
Common
- Palpitations
- Diarrhea
- Anxiety, insomnia, fatigue, sweating, weight loss
- Alopecia
Pharmacology
- Half-life: 6-7 days
- Metabolism: Hepatic
- Excretion: Renal, fecal
Mechanism of Action
- Synthetic thyroid hormone (T4)